Healthcare Unfiltered: Multiple Myeloma With Multiple Guests: A Stakeholder Roundtable on Apple Podcasts
Show Healthcare Unfiltered, Ep Multiple Myeloma With Multiple Guests: A Stakeholder Roundtable – May 31, 2022
Related Articles
What are the Controversies Surrounding MRD in Blood Cancers? | Blood Cancers Today
Alan Skarbnik, MD, and Manni Mohyuddin, MBBS, discuss the concept of MRD in hematologic malignancies.
AI and Drug Development: The future?
In this special episode of Healthcare Unfiltered, I delve into the realm of AI and its transformative impact on drug development with Adam Petrich, MD,…
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma | NEJM
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Healthcare Unfiltered: AI and Drug Development With Adam Petrich on Apple Podcasts
Show Healthcare Unfiltered, Ep AI and Drug Development With Adam Petrich – Apr 23, 2024
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma | NEJM
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma | NEJM
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma | NEJM
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma | NEJM
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
The ABIM-MOC Saga Continues
Dr. Aaron Goodman, who started a petition that gathered over 20,000 signatures to end the MOC back in July 2023, found himself suddenly reported as…
Healthcare Unfiltered: The ABIM-MOC Saga Continues on Apple Podcasts
Show Healthcare Unfiltered, Ep The ABIM-MOC Saga Continues – Apr 16, 2024